Exicure, Inc. SEC filings XCUR
Exicure, Inc. has 532 filings in SEC EDGAR's recent list, going back to Mar 21, 2017. Its latest annual report, Form 10-K, was filed on Mar 25, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 16, 2026 (listing notice). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B3 | Prospectus | Jul 22, 2025 | — |
| S-1 | Registration statement | Jul 11, 2025 | — |
| 424B3 | Prospectus | Jul 20, 2022 | — |
| S-3 | Shelf registration | Jul 11, 2022 | — |
| S-8 | Employee stock plan registration | Mar 25, 2022 | — |
| 424B5 | Prospectus supplement | Dec 16, 2021 | — |
| S-8 | Employee stock plan registration | Mar 12, 2021 | — |
| S-3 | Shelf registration | Dec 21, 2020 | — |
| POS AM | Filing | Jun 8, 2020 | — |
| POS AM | Filing | Jun 8, 2020 | — |
| S-8 | Employee stock plan registration | Mar 10, 2020 | — |
| 424B5 | Prospectus supplement | Dec 20, 2019 | — |
| 424B5 | Prospectus supplement | Dec 18, 2019 | — |
| 424B3 | Prospectus | Nov 7, 2019 | — |
| 424B3 | Prospectus | Nov 7, 2019 | — |
| 424B3 | Prospectus | Sep 24, 2019 | — |
| 424B3 | Prospectus | Sep 24, 2019 | — |
| 424B3 | Prospectus | Aug 9, 2019 | — |
| 424B3 | Prospectus | Aug 9, 2019 | — |
| 424B5 | Prospectus supplement | Aug 1, 2019 | — |
| 424B5 | Prospectus supplement | Jul 30, 2019 | — |
| S-3/A | Filing | Jul 11, 2019 | — |
| 424B3 | Prospectus | May 10, 2019 | — |
| 424B3 | Prospectus | May 10, 2019 | — |
| 424B3 | Prospectus | Mar 19, 2019 | — |
| 424B3 | Prospectus | Mar 19, 2019 | — |
| S-3 | Shelf registration | Mar 8, 2019 | — |
| 424B3 | Prospectus | Nov 6, 2018 | — |
| 424B3 | Prospectus | Nov 6, 2018 | — |
| 424B3 | Prospectus | Oct 11, 2018 | — |
| 424B3 | Prospectus | Oct 9, 2018 | — |
| S-1 | Registration statement | Sep 21, 2018 | — |
| 424B3 | Prospectus | Sep 10, 2018 | — |
| 424B3 | Prospectus | Aug 8, 2018 | — |
| 424B3 | Prospectus | Aug 8, 2018 | — |
| 424B3 | Prospectus | Aug 8, 2018 | — |
| 424B3 | Prospectus | Aug 8, 2018 | — |
| S-8 | Employee stock plan registration | Feb 13, 2018 | — |
| 424B3 | Prospectus | Feb 7, 2018 | — |
| S-1/A | Amended registration statement | Feb 6, 2018 | — |
| S-1/A | Amended registration statement | Jan 26, 2018 | — |
| S-1/A | Amended registration statement | Jan 12, 2018 | — |
| S-1 | Registration statement | Nov 28, 2017 | — |
Showing 43 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- XCUR (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Chicago, IL
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1698530
- Former names
- Max-1 Acquisition Corp (until Sep 28, 2017)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.